About: Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Sector: Healthcare
Industry: Biotechnology
Latest price: $10.70 (+1.52%)
FENC NASDAQ Fennec Pharmaceuticals Inc
Fennec Pharmaceuticals Inc share price
FENC price activity
Last Price
$10.700
Change (24hr)
0.16 USD (1.52%)
Volume
134.95K
Volume (4w avg)
-
Open
$10.63
Day Range
$10.22 - $10.83
Previous Close
$10.54
Last Trade
03 Nov, 9:00 pm GMT+0
Delayed
03 Nov, 9:00 pm GMT+0
FENC price performance
Delayed
03 Nov, 9:00 pm GMT+0
FENC details
FENC Market Signals